These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12807130)

  • 41. Factors associated with recurrent coronary events among patients with cardiovascular disease.
    McConnell KJ; Olson KL; Delate T; Merenich JA;
    Pharmacotherapy; 2009 Aug; 29(8):906-13. PubMed ID: 19637943
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Benefits of risk factor modification through cardiac rehabilitation.
    Borrás IC; Cruz-Jiménez M; Nadal E; Middelhoff A; Rivera A
    Bol Asoc Med P R; 2008; 100(4):75-9. PubMed ID: 19400532
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predictors of angina pectoris versus myocardial infarction from the Women's Health Initiative Observational Study.
    Hsia J; Aragaki A; Bloch M; LaCroix AZ; Wallace R;
    Am J Cardiol; 2004 Mar; 93(6):673-8. PubMed ID: 15019867
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Managing the patient with hypertriglyceridemia: a practical approach for nurse practitioners.
    Rankin FM; Cohen JD
    J Am Acad Nurse Pract; 2008 Dec; 20 Suppl 2():1-14; quiz 15. PubMed ID: 19143900
    [No Abstract]   [Full Text] [Related]  

  • 45. Atypical MI symptoms in women mean delays.
    ED Manag; 2005 Jan; 17(1):6-8. PubMed ID: 15712856
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Aspirin use for prevention of CHD: an FP's story.
    Miser WF
    Am Fam Physician; 2005 Jan; 71(2):250-1, 253. PubMed ID: 15686298
    [No Abstract]   [Full Text] [Related]  

  • 47. Diabetes and coronary heart disease: a time for action.
    Chyun DA
    Crit Care Nurse; 2001 Feb; 21(1):10, 12, 14-6. PubMed ID: 11858236
    [No Abstract]   [Full Text] [Related]  

  • 48. A call to action: bold ideas from the Minnesota Women's Heart Summit.
    Ali N; Lindquist R; Boucher JL; Witt D; Ambroz T; Konety SH; Luepker R; Windenburg D; Hayes SN
    Minn Med; 2012 May; 95(5):44-8. PubMed ID: 22712138
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Heart association issues new guidelines on cardiovascular disease prevention in women.
    Rollins G
    Rep Med Guidel Outcomes Res; 2004 Feb; 15(4):1-2, 6-7. PubMed ID: 15000094
    [No Abstract]   [Full Text] [Related]  

  • 50. Failure of aspirin to prevent myocardial infarction and adverse outcome during follow-up - a large series of all-comers.
    Mikkelsson J; Eskola M; Nikus K; Karhunen PJ; Niemela K
    Ann Med; 2008; 40(4):296-302. PubMed ID: 18428022
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Title V strategies to ensure a continuum of women's health services.
    Kent H; Streeter N
    Womens Health Issues; 2008; 18(6 Suppl):S67-73. PubMed ID: 19059551
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Total cardiovascular risk. When is a medication prophylaxis meaningful].
    Einecke D
    MMW Fortschr Med; 2003 Oct; 145(44):6-8. PubMed ID: 14655495
    [No Abstract]   [Full Text] [Related]  

  • 53. A cross-sectional study of secondary cardiac care in general practice: impact of personal and practice characteristics.
    Byrne M; Murphy AW; Walsh JC; Shryane E; McGroarty M; Kelleher CC
    Fam Pract; 2006 Jun; 23(3):295-302. PubMed ID: 16585129
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).
    Johnson BD; Shaw LJ; Buchthal SD; Bairey Merz CN; Kim HW; Scott KN; Doyle M; Olson MB; Pepine CJ; den Hollander J; Sharaf B; Rogers WJ; Mankad S; Forder JR; Kelsey SF; Pohost GM;
    Circulation; 2004 Jun; 109(24):2993-9. PubMed ID: 15197152
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dose-response relationship between moderate-intensity exercise duration and coronary heart disease risk factors in postmenopausal women.
    Dalleck LC; Allen BA; Hanson BA; Borresen EC; Erickson ME; De Lap SL
    J Womens Health (Larchmt); 2009; 18(1):105-13. PubMed ID: 19132882
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Coronary heart disease. Measures for prevention of cardiovascular incidents].
    Bornkessel B
    Med Monatsschr Pharm; 1996 Aug; 19(8):235-6. PubMed ID: 8965744
    [No Abstract]   [Full Text] [Related]  

  • 57. Preventing heart attack and death in patients with coronary disease.
    Smith SC; Blair SN; Criqui MH; Fletcher GF; Fuster V; Gersh BJ; Gotto AM; Gould KL; Greenland P; Grundy SM
    Circulation; 1995 Jul; 92(1):2-4. PubMed ID: 7788911
    [No Abstract]   [Full Text] [Related]  

  • 58. Preventing heart attack and death in patients with coronary disease. Endorsed by the board of trustees of the American College of Cardiology.
    Smith SC; Blair SN; Criqui MH; Fletcher GF; Fuster V; Gersh BJ; Gotto AM; Gould KL; Greenland P; Grundy SM; Hill MN; Hlatky MA; Houston-Miller N; Krauss RM; LaRosa J; Ockene IS; Oparil S; Pearson TA; Rapaport E; Starke RD
    Cardiovasc Nurs; 1996; 32(4):26-8. PubMed ID: 8846481
    [No Abstract]   [Full Text] [Related]  

  • 59. Aspirin and ischaemic heart disease.
    Br J Hosp Med; 1986 Aug; 36(2):85. PubMed ID: 3527318
    [No Abstract]   [Full Text] [Related]  

  • 60. MI risk in young women.
    Metro LM
    Am J Nurs; 1997 Aug; 97(8):17. PubMed ID: 9267203
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.